Inventor
IRWIN CHEN
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes36%
C07KPeptides36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
PatentTitleYear
12,435,149Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists202512,258,404Bispecific antibody construct directed to MUC17 and CD3202511,692,031Antibody constructs for CLDN18.2 and CD3202311,643,440Peptide PAC1 antagonists202311,186,636Anti-human TREM2 antibodies and uses thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to AMGEN INC (5)· patent assignee history
2021–2025Based in US· patent location history
2023–2025Patents assigned to AMGEN RES MUNICH GMBH (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 5 | 2021–2025 |
| AMGEN RES MUNICH GMBH | 2 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2021–2025 |